| Financial Year |
March 31 2023 |
| Monetary Funds |
470,583,580.65 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,822,974.47 |
| Accounts Receivable |
386,824,276.51 |
| Advances to Suppliers |
32,328,562.59 |
| Other Receivables |
16,303,489.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
62,748,524.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
350,300,548.28 |
| Total Current Assets |
1,947,485,971.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
67,881,532.99 |
| Fixed Assetes |
263,063,153.16 |
| Under-construction Projects |
840,222.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,039,744.56 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
37,739,100.22 |
| Deferred Income Tax Assets |
141,430,515.80 |
| Other Non-Current Assets |
18,593,831.61 |
| Sub-Total of Non-Current Assets |
607,528,303.82 |
| Total Assets |
2,555,014,275.61 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
489,001,556.49 |
| Accounts Received In Advance |
1,335,802.39 |
| Employee Compensation Payable |
23,503,477.96 |
| Taxes Payable |
36,916,421.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,974,920.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,884,484.05 |
| Other Current Liabilities |
119,548,800.61 |
| Sub-Total of Current Liabilities |
847,565,222.90 |
| Long-term Loans |
11,794,388.44 |
| Bonds Payable |
424,836,530.76 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
14,734,150.47 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
493,935,441.98 |
| Total Liabilities |
1,341,500,664.88 |
| Paid-In Capital(Or Share Stock) |
272,043,168.00 |
| Capital Surplus |
548,908,876.62 |
| Surplus Reserve |
74,604,004.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
182,295,433.97 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,213,513,610.73 |
| Owner's Equity（Stockholder's Equity） |
1,213,513,610.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,555,014,275.61 |
